UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7261) 7261
Book Chapter (114) 114
Publication (8) 8
Magazine Article (7) 7
Newspaper Article (6) 6
Conference Proceeding (3) 3
Poster (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rituximab (6548) 6548
humans (6141) 6141
science & technology (5840) 5840
life sciences & biomedicine (5773) 5773
female (3475) 3475
male (3439) 3439
middle aged (2929) 2929
adult (2452) 2452
aged (2272) 2272
treatment outcome (2100) 2100
antibodies, monoclonal, murine-derived (1936) 1936
hematology (1852) 1852
oncology (1670) 1670
antibodies, monoclonal - therapeutic use (1462) 1462
antineoplastic combined chemotherapy protocols - therapeutic use (1273) 1273
antibodies, monoclonal, murine-derived - therapeutic use (1170) 1170
antibodies, monoclonal - adverse effects (1014) 1014
care and treatment (936) 936
antibodies, monoclonal, murine-derived - adverse effects (922) 922
aged, 80 and over (904) 904
rituximab - therapeutic use (897) 897
lymphoma (846) 846
retrospective studies (842) 842
antibodies, monoclonal, murine-derived - administration & dosage (836) 836
immunologic factors - therapeutic use (822) 822
antineoplastic combined chemotherapy protocols - adverse effects (816) 816
chemotherapy (808) 808
rheumatology (782) 782
antineoplastic agents - therapeutic use (781) 781
immunosuppressive agents - therapeutic use (755) 755
transplantation (754) 754
patients (748) 748
medicine & public health (740) 740
antibodies, monoclonal - administration & dosage (733) 733
cancer (721) 721
adolescent (707) 707
lymphomas (696) 696
young adult (696) 696
drug therapy (664) 664
immunology (664) 664
cyclophosphamide - administration & dosage (651) 651
antineoplastic agents - adverse effects (635) 635
risk factors (620) 620
recurrence (618) 618
rituximab - adverse effects (603) 603
abridged index medicus (601) 601
rituximab - administration & dosage (594) 594
prognosis (588) 588
remission induction (544) 544
cyclophosphamide (538) 538
immunotherapy (527) 527
follow-up studies (522) 522
disease-free survival (518) 518
monoclonal antibodies (516) 516
antineoplastic combined chemotherapy protocols - administration & dosage (515) 515
antineoplastic agents (514) 514
lymphoma, large b-cell, diffuse - drug therapy (511) 511
rheumatoid arthritis (510) 510
antimitotic agents (492) 492
health aspects (474) 474
analysis (472) 472
child (470) 470
clinical trials (464) 464
vincristine - administration & dosage (456) 456
drug therapy, combination (453) 453
hemic and lymphatic diseases (445) 445
research (439) 439
drug administration schedule (438) 438
doxorubicin - administration & dosage (433) 433
arthritis, rheumatoid - drug therapy (426) 426
time factors (424) 424
immunologic factors - adverse effects (421) 421
antirheumatic agents - therapeutic use (414) 414
immunosuppressive agents - adverse effects (412) 412
prednisone - administration & dosage (412) 412
pharmacology & pharmacy (404) 404
cyclophosphamide - therapeutic use (400) 400
leukemia, lymphocytic, chronic, b-cell - drug therapy (397) 397
cyclophosphamide - adverse effects (390) 390
lymphocytes b (388) 388
general & internal medicine (374) 374
lymphoma, non-hodgkin - drug therapy (371) 371
b-lymphocytes - immunology (365) 365
medicine, general & internal (356) 356
lymphoma, b-cell - drug therapy (354) 354
antineoplastic agents - administration & dosage (346) 346
pediatrics (346) 346
corticosteroids (344) 344
combined modality therapy (339) 339
antirheumatic agents - adverse effects (336) 336
immune system diseases (330) 330
antigens, cd20 - immunology (320) 320
medical research (320) 320
immunoglobulins (316) 316
internal medicine (315) 315
surgery (315) 315
animals (313) 313
prospective studies (313) 313
lymphoma, follicular - drug therapy (310) 310
b-lymphocytes - drug effects (304) 304
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7171) 7171
Japanese (59) 59
Spanish (58) 58
German (55) 55
French (51) 51
Chinese (37) 37
Italian (19) 19
Russian (13) 13
Portuguese (12) 12
Czech (9) 9
Korean (7) 7
Polish (7) 7
Croatian (6) 6
Danish (6) 6
Hungarian (4) 4
Dutch (3) 3
Finnish (2) 2
Hebrew (2) 2
Norwegian (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of clinical oncology, ISSN 1527-7755, 07/2011, Volume 29, Issue 20, pp. 2766 - 2772
Journal Article
Journal Article
Journal Article
Annals of hematology, ISSN 1432-0584, 10/2017, Volume 97, Issue 1, pp. 141 - 147
Pneumonitis is a rare but severe and potentially fatal adverse effect in chemotherapy of lymphoma... 
Non-Hodgkin’s lymphoma | Chemotherapy | Medicine & Public Health | Hematology | Interstitial pneumonitis | Rituximab | Oncology | Pegylated liposomal doxorubicin | Life Sciences & Biomedicine | Science & Technology | Antineoplastic Agents, Immunological - administration & dosage | Cyclophosphamide - administration & dosage | Immunotherapy - methods | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyethylene Glycols - adverse effects | Male | Lung Diseases, Interstitial - chemically induced | Cyclophosphamide - adverse effects | Incidence | Doxorubicin - analogs & derivatives | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Daunorubicin - administration & dosage | Lung Diseases, Interstitial - epidemiology | Doxorubicin - administration & dosage | Lymphoma, Non-Hodgkin - drug therapy | Rituximab - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Lymphoma, Non-Hodgkin - epidemiology | Polyethylene Glycols - administration & dosage | Daunorubicin - adverse effects | Rituximab - administration & dosage | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Medical research | Pneumonia | Anthracyclines | Corticosteroids | Analysis | Bacterial pneumonia | Medicine, Experimental | Lymphomas | Cancer | Lymphoma | Neutropenia | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 05/2019, Volume 37, Issue 15, pp. 1285 - 1295
Journal Article
The Lancet (British edition), ISSN 0140-6736, 04/2013, Volume 381, Issue 9873, pp. 1203 - 1210
Summary Background Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Nitrogen Mustard Compounds - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Vincristine - administration & dosage | Adult | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Treatment Outcome | Nitrogen Mustard Compounds - adverse effects | Disease-Free Survival | Bendamustine Hydrochloride | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Aged | Infusions, Intravenous | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Usage | Chemotherapy | Bendamustine | Patient outcomes | Lymphomas | Research | Drug therapy | Comparative analysis | Cancer | Antimitotic agents | Care and treatment | Antineoplastic agents | Analysis | Bone marrow | Hematology | Lymphoma | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 05/2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Hematology | Science & Technology | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Infections - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced | Index Medicus
Journal Article
Journal Article